Square Face Aesthetics: A Dilemma for Men
A wide jaw and prominent masseter muscles were long considered symbols of strength and masculinity. However, from the mid-2020s onward, male aesthetic demands have undergone a profound transformation. Approximately 38% of male patients presenting at Virtuana Clinic now use the phrase "not square, but V-line." This demand has grown particularly among professional men aged 25–40.
A square face is not inherently unattractive; however, an enlarged masseter can make the face appear coarser and more tired over time. Masseter hypertrophy is frequently associated with bruxism (teeth grinding), stress, or hereditary factors. In such cases, facial slimming becomes both an aesthetic and a functional requirement.
The Masseter Muscle: Anatomical Fundamentals
The masseter is the most powerful muscle in the face, capable of generating approximately 70–150 kg of force. It comprises three layers: superficial, middle, and deep. Hypertrophy most commonly occurs in the superficial portion and is the primary anatomical structure determining facial width. At Virtuana Clinic, ultrasound imaging is used to assess muscle thickness, enabling objective measurement of muscle volume before and after treatment.
| Measurement Parameter | Normal Value | Hypertrophy Threshold | Post-Treatment Target |
|---|---|---|---|
| Muscle thickness (at rest) | 12–15 mm | > 18 mm | 13–15 mm |
| Muscle thickness (contracted) | 16–20 mm | > 25 mm | 17–19 mm |
| Facial width (bizygomatic) | 140–148 mm | > 152 mm | 140–145 mm |
| Gonial angle | 120–130° | < 115° | 122–128° |
Masseter Botox in Men: Differences from Women
The male masseter muscle is on average 40% thicker and stronger than in women. Standard doses are therefore insufficient for men. According to the Virtuana Clinic protocol, 30–40 IU of botulinum toxin A is administered per side in men — significantly higher than the 20–25 IU used in women. Injection depth is also critical: fine needles of 13 mm or longer are preferred to reach the middle muscle layer rather than the superficial muscle fibers.
An important technical consideration: the injection must remain within the boundaries of the masseter. Incorrect anatomical placement can affect the zygomaticus major muscle and cause asymmetry in voluntary smile. This complication underscores the importance of selecting an experienced physician.
Ultrasound-Guided Muscle Thickness Monitoring
The masseter botulinum toxin protocol at Virtuana Clinic involves a three-phase measurement process. Before treatment, ultrasound maps muscle thickness, boundaries, and vascular anatomy. This map forms the basis of injection planning. A follow-up ultrasound at 6–8 weeks post-treatment assesses the degree of atrophy; a 25–35% reduction in muscle thickness is typically expected. A second-year review monitors long-term muscle adaptation: the muscle not only undergoes atrophy but may also develop fibrous changes, which can require lower doses in subsequent sessions.
The Aesthetic "Bonus Effect" of Bruxism Treatment
Teeth grinding (bruxism) is a medical condition that causes dental wear, temporomandibular joint pain, and headaches. Masseter botulinum toxin is one of the first-line treatments for bruxism and is referenced in the guidelines of the Turkish Dental Association and the European Academy of Craniomandibular Disorders. The majority of male patients who receive masseter botulinum toxin for bruxism unexpectedly report that their face appears slimmer and their jawline more defined. This "bonus effect" is the main reason men with no aesthetic motivation become interested in the procedure.
Combined Approach: Masseter + Chin + Cheek Filler Synergy
The most effective facial slimming results are achieved with combined protocols. Masseter botulinum toxin alone slims the upper portion of the jaw, but when chin projection is insufficient, the face may still be perceived as wide overall. For this reason, the V-line protocol at Virtuana Clinic comprises three components:
- Masseter botulinum toxin: Reduces facial width and softens pronounced muscle hypertrophy
- Chin botulinum toxin (mentalis): Corrects chin tip appearance and eliminates the "orange peel" texture
- Chin tip filler (1–2 mL HA): Provides vertical projection, visually elongates the face and completes the V-line effect
The synergistic effect of these three components creates approximately twice the perceived facial slimming compared with masseter botulinum toxin alone.
When Does the V-Line Effect Become Visible?
The effect of masseter botulinum toxin emerges gradually. During the first 2 weeks a slight reduction in muscle bulk is felt, but visual change is not yet apparent. Between weeks 4 and 6 visible slimming begins, and patients notice their face looking thinner. Weeks 8 to 12 represent the period of maximum effect; the reduction in muscle thickness is directly reflected in facial contour. This is typically when the change starts to be noticed in social settings.
| Timeline | Expected Change | Patient Feedback |
|---|---|---|
| Weeks 1–2 | Muscle weakness begins | Possible chewing difficulty |
| Weeks 4–6 | Visible slimming begins | "My face looks a bit thinner" |
| Weeks 8–12 | Maximum effect | "People around me noticed" |
| Months 6–9 | Effect begins to diminish | Follow-up appointment booked |
Repeat Treatment and Long-Term Muscle Adaptation
Masseter botulinum toxin is a temporary procedure; the duration of effect in men is typically 6–9 months. However, regular repeat treatments offer an important advantage: the muscle shows progressively greater atrophy after each session, and lower doses become sufficient in subsequent treatments. A patient who required 35 IU per side at the first session may achieve the same result with 20–25 IU at the third session. This is beneficial in terms of both cost and treatment frequency. According to Virtuana Clinic data, 62% of patients receiving regular treatment are able to extend their session intervals to 9–12 months from the third year onward.
Who Is Not a Suitable Candidate?
Masseter botulinum toxin may not be appropriate for every man. In men who already have a thin face with minimal masseter volume, the procedure is unnecessary and may make the face appear excessively sunken. Additionally, patients with myasthenia gravis, Lambert-Eaton syndrome, or neuromuscular disease fall into the contraindicated category. In men taking anticoagulant medications, discontinuation before injection should be assessed. Patients actively being treated for bruxism and under the care of a dentist should request coordinated planning with both clinicians.
Frequently Asked Questions about Male Facial Slimming
Will there be difficulty speaking or eating after the procedure? It is recommended to avoid foods requiring forceful chewing during the first 1–2 weeks. Hard meats, shelled nuts, and chewing gum should be restricted during this period. Speech is generally not significantly affected.
Does exercise affect the results? In men who engage in bodybuilding and heavy training, high protein intake and movements that place indirect load on the jaw area (such as clenching while lifting) can shorten the duration of the botulinum toxin effect. Dose adjustment and more frequent monitoring are recommended for these patients.
What is the cost at Virtuana Clinic? Masseter botulinum toxin for men (both sides) is priced as a single-session fee according to the clinic's current price list. For combined protocols, an individual quote is prepared at the time of consultation.
The Virtuana Clinic Approach: V-Line Protocol in Izmit/Kocaeli
Virtuana Clinic aims to be one of the leading centers in the Kocaeli region for male facial aesthetics. The clinic is one of a small number of centers that performs ultrasound assessment before masseter botulinum toxin and applies dosing protocols tailored to male anatomy. Dedicated men's aesthetics consultation days are organized for male patients from Izmit, Gebze, Darica, and the Korfez area. You can reach us via the clinic's contact page to book an appointment.
This article is for informational purposes only. Please consult a qualified physician for treatment decisions.